Publications by authors named "A H Drummond"
Introduction: The majority of orthodontic patients present with plaquebiofilm and related manifestations in the early stages of active fixed orthodontic appliance use.
Aims: To evaluate the effects of a slow-delivery chlorhexidine:beta-cyclodextrin (Cx:β-Cd) gel compared with those of free Cx free formulations on clinical parameters in patients undergoing treatment with fixed orthodontic appliances.
Methods: Patients aged 12-18 years received prophylaxis and scaling and were randomised to treatment groups in a double-blinded manner.
Case: Fourteen-year-old boy, history of autism presented with bilateral knee instability. Imaging revealed bilateral anterior cruciate ligament (ACL) insufficiency, 20° of posterior tibial slope (PTS) on the right and 18° on the left. A guided growth technique using anterior placed tension band plates was used to correct the PTS.
View Article and Find Full Text PDFBiology has become a highly mathematical discipline in which probabilistic models play a central role. As a result, research in the biological sciences is now dependent on computational tools capable of carrying out complex analyses. These tools must be validated before they can be used, but what is understood as validation varies widely among methodological contributions.
View Article and Find Full Text PDFArticle Synopsis
- Non-adherence to splint wearing after upper limb injuries is a major medical challenge, impacting patient outcomes and increasing healthcare costs.
- A systematic review of 16 articles highlighted the varied methods used to measure splint adherence, with no widely accepted tools or standards in place.
- The study calls for consistent measurement practices to enhance research quality and improve adherence among patients, which could lead to better recovery outcomes.
Background: Although clozapine is the most effective antipsychotic for people with treatment-resistant schizophrenia (TRS), only 40% of people with TRS respond, and there is limited evidence for augmentation agents. Cannabidiol (CBD) reduces positive symptoms in individuals with schizophrenia, but no trials have specifically examined its efficacy in those with clozapine-resistant schizophrenia.
Aims: To examine the clinical efficacy of CBD augmentation in people with clozapine-resistant schizophrenia.